These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 24156409

  • 1. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells.
    Bo H, Zhang S, Gao L, Chen Y, Zhang J, Chang X, Zhu M.
    BMC Cancer; 2013 Oct 25; 13():496. PubMed ID: 24156409
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-148a suppresses epithelial-mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β-catenin signaling pathway.
    Peng L, Liu Z, Xiao J, Tu Y, Wan Z, Xiong H, Li Y, Xiao W.
    Oncol Rep; 2017 Jul 25; 38(1):301-308. PubMed ID: 28586066
    [Abstract] [Full Text] [Related]

  • 3. Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer.
    Wang B, Tang Z, Gong H, Zhu L, Liu X.
    Biosci Rep; 2017 Dec 22; 37(6):. PubMed ID: 29054966
    [Abstract] [Full Text] [Related]

  • 4. Upregulation of the expression of Wnt5a promotes the proliferation of pancreatic cancer cells in vitro and in a nude mouse model.
    Bo H, Gao L, Chen Y, Zhang J, Zhu M.
    Mol Med Rep; 2016 Feb 22; 13(2):1163-71. PubMed ID: 26648282
    [Abstract] [Full Text] [Related]

  • 5. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
    Li J, Yang R, Dong Y, Chen M, Wang Y, Wang G.
    J Exp Clin Cancer Res; 2019 Jan 28; 38(1):38. PubMed ID: 30691517
    [Abstract] [Full Text] [Related]

  • 6. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling.
    Hu W, Wang Z, Zhang S, Lu X, Wu J, Yu K, Ji A, Lu W, Wang Z, Wu J, Jiang C.
    Sci Rep; 2019 May 17; 9(1):7539. PubMed ID: 31101875
    [Abstract] [Full Text] [Related]

  • 7. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
    He YM, Xiao YS, Wei L, Zhang JQ, Peng CH.
    J Cell Biochem; 2018 Jul 17; 119(7):5308-5323. PubMed ID: 29274277
    [Abstract] [Full Text] [Related]

  • 8. Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition.
    Cheng R, Sun B, Liu Z, Zhao X, Qi L, Li Y, Gu Q.
    J Cell Physiol; 2014 Dec 17; 229(12):1908-17. PubMed ID: 24464650
    [Abstract] [Full Text] [Related]

  • 9. [Expression of Wnt5a, APC, β-catenin and their clinical significance in human colorectal adenocarcinoma].
    Cao YC, Yang F, Liu XH, Xin X, Wang CC, Geng M.
    Zhonghua Zhong Liu Za Zhi; 2012 Sep 17; 34(9):674-8. PubMed ID: 23159080
    [Abstract] [Full Text] [Related]

  • 10. WNT5A modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells.
    Wei W, Sun HH, Li N, Li HY, Li X, Li Q, Shen XH.
    Hepatobiliary Pancreat Dis Int; 2014 Oct 17; 13(5):529-38. PubMed ID: 25308364
    [Abstract] [Full Text] [Related]

  • 11. TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells.
    Wu J, Li H, Shi M, Zhu Y, Ma Y, Zhong Y, Xiong C, Chen H, Peng C.
    J Exp Clin Cancer Res; 2019 Aug 09; 38(1):348. PubMed ID: 31399111
    [Abstract] [Full Text] [Related]

  • 12. Wnt5a promotes vasculogenic mimicry and epithelial-mesenchymal transition via protein kinase Cα in epithelial ovarian cancer.
    Qi H, Sun B, Zhao X, Du J, Gu Q, Liu Y, Cheng R, Dong X.
    Oncol Rep; 2014 Aug 09; 32(2):771-9. PubMed ID: 24898696
    [Abstract] [Full Text] [Related]

  • 13. WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer.
    Griesmann H, Ripka S, Pralle M, Ellenrieder V, Baumgart S, Buchholz M, Pilarsky C, Aust D, Gress TM, Michl P.
    Neoplasia; 2013 Jan 09; 15(1):11-22. PubMed ID: 23359789
    [Abstract] [Full Text] [Related]

  • 14. WNT5A is a key regulator of the epithelial-mesenchymal transition and cancer stem cell properties in human gastric carcinoma cells.
    Kanzawa M, Semba S, Hara S, Itoh T, Yokozaki H.
    Pathobiology; 2013 Jan 09; 80(5):235-44. PubMed ID: 23615002
    [Abstract] [Full Text] [Related]

  • 15. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas.
    Li L, Ying J, Tong X, Zhong L, Su X, Xiang T, Shu X, Rong R, Xiong L, Li H, Chan AT, Ambinder RF, Guo Y, Tao Q.
    Cell Mol Life Sci; 2014 Jun 09; 71(11):2179-92. PubMed ID: 24158497
    [Abstract] [Full Text] [Related]

  • 16. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase.
    Yamamoto H, Oue N, Sato A, Hasegawa Y, Yamamoto H, Matsubara A, Yasui W, Kikuchi A.
    Oncogene; 2010 Apr 08; 29(14):2036-46. PubMed ID: 20101234
    [Abstract] [Full Text] [Related]

  • 17. The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer.
    Ford CE, Punnia-Moorthy G, Henry CE, Llamosas E, Nixdorf S, Olivier J, Caduff R, Ward RL, Heinzelmann-Schwarz V.
    Gynecol Oncol; 2014 Aug 08; 134(2):338-45. PubMed ID: 24924122
    [Abstract] [Full Text] [Related]

  • 18. WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer.
    Ripka S, König A, Buchholz M, Wagner M, Sipos B, Klöppel G, Downward J, Gress T, Michl P.
    Carcinogenesis; 2007 Jun 08; 28(6):1178-87. PubMed ID: 17227781
    [Abstract] [Full Text] [Related]

  • 19. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis.
    Geng M, Cao YC, Chen YJ, Jiang H, Bi LQ, Liu XH.
    World J Gastroenterol; 2012 Mar 28; 18(12):1328-38. PubMed ID: 22493546
    [Abstract] [Full Text] [Related]

  • 20. EGF-reduced Wnt5a transcription induces epithelial-mesenchymal transition via Arf6-ERK signaling in gastric cancer cells.
    Zhang Y, Du J, Zheng J, Liu J, Xu R, Shen T, Zhu Y, Chang J, Wang H, Zhang Z, Meng F, Wang Y, Chen Y, Xu Y, Gu L.
    Oncotarget; 2015 Mar 30; 6(9):7244-61. PubMed ID: 25779663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.